Clinical Trials
Kiadis Pharma raises fund for Phase II study of ATIR
Kiadis Pharma has raised EUR10m in a financing round to conduct Phase II study of a cell based medicinal product candidate, ATIR, and...
Press Releases
Diffusion Pharmaceuticals Successfully Completes Phase I Brain Cancer Trial
Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of...
News
TGen, Scottsdale Healthcare lead worldwide study of new drug for patients with pancreatic cancer
A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according...
Drug Research
Aptar Pharma names Jean-Marc Pardonge as prescription division new president
Aptar Pharma, a subsidiary of Aptargroup, has named Jean-Marc Pardonge as the new president for the company's prescription division. ...
Clinical Trials
Pfizer Phase 3 fibromyalgia study of pregabalin meets primary endpoint
Pfizer Phase III study of pregabalin controlled-release (CR) formulation has met primary endpoint of time to loss of therapeutic response (LTR), in fibromyalgia...
News
Study shows large-scale genomic testing feasible, impacts therapy
Targeted cancer therapy has been transforming the care of patients with non-small-cell lung cancer (NSCLC). It is now standard practice...
Press Releases
State of the Cure Report Finds Funding of Cure Research for Type 1 Diabetes Drops by Half
On November 19, 2012, the Juvenile Diabetes Cure Alliance announced the release of their annual research report, State of the Cure, which is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read